This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
Any discussion of therapy in rheumatic fever must, of course, be concerned with the extremely important aspect of prevention as well as with treatment of the attack which has already begun. The measures of importance in prevention can be stated with confidence in the light of progress made over the past 30 years. Unfortunately, however, one can write with far less certainty about the treatment of the established attack. In this presentation, both prevention and treatment will be considered and the evidence for and against the important unsettled issues will be briefly discussed. In addition, some aspects of the treatment of patients with inactive rheumatic heart disease will be included.
The evidence that rheumatic fever does not occur without a preceding infection due to a group A hemolytic streptococcus is now so well established that it is necessary to mention only a few of the more important recent studies
McEwen C. CURRENT STATUS OF THERAPY IN RHEUMATIC FEVER. JAMA. 1959;170(9):1056–1062. doi:10.1001/jama.1959.63010090007011
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: